JAMPLYTE
JAMPLYTE
Approved
DIN Number
02378329
Drug Class
Human
Market Date
Jun 17, 2025
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02378329
AIG Number0524479007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A06AD65 MACROGOL, COMBINATIONS
Product Specifications
Dosage FormPowder
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
POLYETHYLENE GLYCOL 3350Active
Strength: 238.2 G / 280 G
Monograph: POLYETHYLENE GLYCOL 3350
POTASSIUM CHLORIDEActive
Strength: 3.04 G / 280 G
Monograph: POTASSIUM CHLORIDE
SODIUM BICARBONATEActive
Strength: 6.76 G / 280 G
Monograph: SODIUM BICARBONATE
SODIUM CHLORIDEActive
Strength: 5.84 G / 280 G
Monograph: SODIUM CHLORIDE
SODIUM SULFATEActive
Strength: 22.96 G / 280 G
Monograph: SODIUM SULFATE